Umer Raffat
Stock Analyst at Evercore ISI
(4.14)
# 1,581
Out of 5,051 analysts
155
Total ratings
51.7%
Success rate
9.1%
Average return
Main Sectors:
Stocks Rated by Umer Raffat
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KOD Kodiak Sciences | Reiterated: Buy | n/a | $99.26 | - | 4 | Sep 28, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Hold | n/a | $1,182.62 | - | 15 | Sep 23, 2026 | |
| APMD Apnimed | Initiated Coverage: Buy | n/a | $18.63 | - | 1 | Aug 25, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | n/a | $150.43 | - | 16 | Aug 5, 2026 | |
| PBLS Parabilis Medicines | Initiated Coverage: Buy | n/a | $28.95 | - | 1 | Jul 6, 2026 | |
| SYRE Spyre Therapeutics | Reiterated: Buy | n/a | $85.90 | - | 6 | Jun 3, 2026 | |
| PCVX Vaxcyte | Reiterated: Buy | n/a | $70.65 | - | 2 | May 21, 2026 | |
| BIIB Biogen | Initiated Coverage: Buy | n/a | $229.41 | - | 8 | May 15, 2026 | |
| KLRA Kailera Therapeutics | Initiated Coverage: Buy | n/a | $11.33 | - | 1 | May 12, 2026 | |
| ELAN Elanco Animal Health | Reiterated: Buy | n/a | $22.56 | - | 6 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $417.57 | - | 17 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.64 | - | 6 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $28.40 | - | 8 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.77 | - | 7 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $5.03 | +98.81% | 3 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $57.78 | - | 3 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $40.26 | - | 6 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $22.23 | - | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $24.34 | n/a | 6 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.41 | n/a | 2 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.80 | n/a | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.44 | n/a | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $145.45 | n/a | 3 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $16.07 | n/a | 1 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $27.48 | n/a | 4 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $7.13 | n/a | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $17.80 | n/a | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.54 | n/a | 6 | Dec 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $216.75 | n/a | 5 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $134.38 | n/a | 3 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.72 | n/a | 2 | Jun 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $18.30 | n/a | 1 | Mar 9, 2018 |
Kodiak Sciences
Sep 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $99.26
Upside: -
Eli Lilly and Company
Sep 23, 2026
Reiterated: Hold
Price Target: n/a
Current: $1,182.62
Upside: -
Apnimed
Aug 25, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $18.63
Upside: -
Gilead Sciences
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $150.43
Upside: -
Parabilis Medicines
Jul 6, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $28.95
Upside: -
Spyre Therapeutics
Jun 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $85.90
Upside: -
Vaxcyte
May 21, 2026
Reiterated: Buy
Price Target: n/a
Current: $70.65
Upside: -
Biogen
May 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $229.41
Upside: -
Kailera Therapeutics
May 12, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $11.33
Upside: -
Elanco Animal Health
May 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.56
Upside: -
May 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $417.57
Upside: -
Apr 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $8.64
Upside: -
Apr 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $28.40
Upside: -
Apr 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $13.77
Upside: -
Mar 9, 2026
Reiterated: Buy
Price Target: $10
Current: $5.03
Upside: +98.81%
Feb 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $57.78
Upside: -
Nov 12, 2025
Reiterated: Buy
Price Target: n/a
Current: $40.26
Upside: -
Nov 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $22.23
Upside: -
Oct 8, 2025
Reiterated: Buy
Price Target: n/a
Current: $24.34
Upside: n/a
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $4.41
Upside: n/a
May 12, 2025
Reiterated: Buy
Price Target: n/a
Current: $19.80
Upside: n/a
Feb 21, 2025
Reiterated: Buy
Price Target: n/a
Current: $8.44
Upside: n/a
Feb 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $145.45
Upside: n/a
Oct 15, 2024
Upgraded: Buy
Price Target: n/a
Current: $16.07
Upside: n/a
Mar 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $27.48
Upside: n/a
May 11, 2023
Upgraded: Buy
Price Target: n/a
Current: $7.13
Upside: n/a
Nov 1, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $17.80
Upside: n/a
Dec 9, 2021
Reiterated: Buy
Price Target: n/a
Current: $17.54
Upside: n/a
Jan 28, 2021
Reiterated: Buy
Price Target: n/a
Current: $216.75
Upside: n/a
Jul 20, 2020
Reiterated: Buy
Price Target: n/a
Current: $134.38
Upside: n/a
Jun 4, 2019
Reiterated: Buy
Price Target: n/a
Current: $3.72
Upside: n/a
Mar 9, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $18.30
Upside: n/a